Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus

Clinical Endocrinology

Volumn 58, Issue 4, 2003, Pages 415-420

  Dane Stewart, C A ^a   Watts, Gerald F ^a,c   Barrett, P H R ^a   Stuckey, B G A ^b   Mamo, J C L ^d   Martins, I J ^a   Redgrave, T G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; APOLIPOPROTEIN C3; CHYLOMICRON;

ADULT; ARTICLE; ATHEROSCLEROSIS; BREATH ANALYSIS; CATABOLISM; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOELECTROPHORESIS; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK FACTOR; TURBIDIMETRY;

APOLIPOPROTEIN B-48; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BREATH TESTS; CARBON ISOTOPES; CASE-CONTROL STUDIES; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOELECTROPHORESIS; ISOTOPE LABELING; MIDDLE AGED; POSTMENOPAUSE; RISK; STATISTICS, NONPARAMETRIC;

EID: 0037380270     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01731.x     Document Type: Article

References (25)

1. van Beck, A.P., de Ruijter-Heijstek, F.C., Erkelens, D.W. & de Bruin, T.W.A. (1999) Menopause is associated with reduced protection from post-prandial lipaemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 2737-2741.
2. Blaak, E.E., vanAggel-Leijssen, D.P.C., Wagenmakers, A.J.M., Saris, W.H.M. & van Baak, M.A. (2000) Impaired oxidation of plasma-derived fatty acids in type2 diabetic subjects during moderate-intensity exercise. Diabetes, 49, 2102-2107.
3. Brewer, H.B. (1999) Hypertriglyceridaemia: changes in the plasma lipoproteins associated with the increased risk of cardiovascular disease. American Journal of Cardiology, 83, 3F-12F.
4. Brown, W.V. & Baginsky, M.L. (1972) Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochimica et Biophysica Acta, 46, 375-382.
5. Chen, Y.-D.I., Swami, S., Skowronski, R., Coulston, A. & Reaven, G.M. (1993) Differences in postprandial lipaemia between patients with normal glucose tolerance and noninsulin-dependant diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 76, 172-177.
6. Cohn, J.S. (1998) Postprandial lipaemia: emerging evidence for atherogenicity of remnant lipoproteins. Canadian Journal of Cardiology, 14, 18B-27B.
7. Curtin, A., Deegan, P., Owens, D., Collins, P., Johnson, A. & Tomkin, G.H. (1996) Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetologica, 33, 205-210.
8. De Man, F.H.A.F., Castro Cabezas, M., van Barlingen, H.H.J.J., Erkelens, D.W. & de Bruin, T.W.A. (1996) Triglyceride-rich lipoproteins in non-insulindependant diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis. European Journal of Clinical Investigation, 26, 89-108.
9. Ebara, T., Conde, K., Kako, Y., Liu, Y., Xu, Y., Ramakrishnan, R., Goldberg, I.J. & Shachter, N.S. (2000) Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. Journal of Clinical Investigation, 105, 1807-1818.
10. Gervaise, N., Garrigue, M.A., Lasfargues, G. & Lecomte, P. (2000) Triglycerides, apoC3 and Lp B:C3 and cardiovascular risk in type II diabetes. Diabetologia, 43, 703-708.
11. Gleeson, A., Anderton, K., Owens, D., Bennett, A., Collins, P., Johnson, A., White, D. & Tomkin, G.H. (1999) The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia, 42, 944-948.
12. Hu, F.B., Stampfer, M.J., Solomon, C.G., Liu, S., Willett, W.C., Speizer, F.E., Nathan, D.M. & Manson, J.E. (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Archives of Internal Medicine, 161, 1717-1723.
13. Lewis, G.F., O'Meara, N.M., Soltys, P.A., Blackman, J.D., Iverius, P.H., Pugh, W.L., Getz, G.S. & Polonsky, K.S. (1991) Fasting hypertriglyceridemia in noninsulin-dependant diabetes mellitus is an important predictor of postprandial lipid and lipid abnormalities. Journal of Clinical Endocrinology and Metabolism, 72, 934-944.
14. Li, W.W., Dammerman, M.M., Smith, J.D., Metsger, S., Breslow, J.L. & Leff, T. (1995) Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. Journal of Clinical Investigation, 96, 2601-2605.
15. Luiken, J.J.F., Dyck, D.J., Han, X.-X., Tandon, N.N., Arumugam, Y., Glatz, J.F.C. & Bonen, A. (2002) Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. American Journal of Physiology. Endocrinology and Metabolism, 282, E491-E495.
16. Mamo, J.C.L., Szeto, L. & Steiner, G. (1990) Glycation of very low density lipoproteins from rat plasma impairs it metabolism. Diabetologia, 33, 339-345.
17. Martins, I.J., Hone, E., Chi, C., Seydel, U., Martins, R.N. & Redgrave, T.G. (2000) Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. Journal of Lipid Research, 41, 205-213.
18. 2 breath test to assess the metabolism of triglyceride-rich lipoprotein remnants in mice. Journal of Lipid Research, 39, 691-698.
19. Reaven, G. & Ida Chen, Y. (1988) Role of insulin regulation of lipoprotein metabolism in diabetes. Diabetes/Metabolism Reviews, 4, 639-652.
20. Redgrave, T.G., Watts, G.F., Martins, I.J., Dimmitt, S.B. & Marais, A.D. (2001) Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. Journal of Lipid Research, 42, 710-715.
21. Shachter, N.S. (2001) Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Current Opinion in Lipidology, 12, 297-304.
22. Smith, D., Watts, G.F., Dane-Stewart, C.A. & Mamo, J.C.L. (1999) Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B-48 in the fasting state. European Journal of Clinical Investigation, 29, 204-209.
23. Teno, S., Uto, Y., Nagashima, H., Endoh, Y., Iwamoto, Y., Omori, Y. & Takizawa, T. (2000) Association of postprandial hypertriglyceridaemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care, 23, 1401-1406.
24. Watts, G.F., Chan, D.C.F., Barrett, P.H.R., Martins, I.J. & Redgrave, T.G. (2001) Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity. Clinical Science, 101, 683-690.
25. Windler, E. & Havel, R.J. (1985) Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. Journal of Lipid Research, 26, 556-563.